電子期刊
台灣家庭醫學雜誌
專論(Monograph)
迎接台灣急性呼吸道感染疾病防治挑戰:推動「左流右新」疫苗同時接種政策
COVID-19疫苗、流感疫苗、同時接種、疫苗政策
吳至行1,2,3
、張峰義11
、盛望徽8
、陳宏麟12
、周慶明13
、賈 蔚14
、李翠鳳15
、莊人祥16*
、黃振國17*
、黃立民4
、邱政洵5,6
、陳宜君7,8
、王復德9,10
國立成功大學醫學院醫學系家庭醫學科1
、國立成功大學醫學院附設醫院家庭醫學部10
、國立成功大學醫學院老年學研究所11
、國立臺灣大學醫學院附設醫院小兒科12
、林口長庚紀念醫院分子感染症醫學研究中心13
、長庚大學醫學系兒童感染科14
、國立臺灣大學醫學院附設醫院內科部感染科15
、國立臺灣大學醫學院內科16
、臺北醫學大學附設醫院感染科17
、國立陽明大學醫學系內科2
、三軍總醫院感染及熱帶醫學科3
、陳宏麟診所4
、錦明耳鼻喉科診所5
、桃園巿衛生局6
、台南巿衛生局7
、衛生福利部疾病管制署8
、黃振國診所9
迎接台灣急性呼吸道感染疾病防治挑戰:推動「左流右新」疫苗同時接種政策
吳至行1,2,3 黃立民4 邱政洵5,6 陳宜君7,8 王復德9,10 張峰義11 盛望徽8 陳宏麟12 周慶明13 賈 蔚14 李翠鳳15 莊人祥16* 黃振國17*
台灣及全球進入後疫情時代,新冠病毒與流感病毒仍持續共同流行。然而台灣民眾在國內醫療照護完備下的防疫意識逐漸疲乏導致新冠及流感疫苗接種率偏低,恐不足以應對感染高峰及病毒帶來的長期疾病負擔。國際間在過去幾年推動新冠與流感疫苗同時接種,並已證明其安全性與有效性。台灣家庭醫學醫學會與多個國內醫療專業學(協)會、全國醫師公會聯合會及政府主要決策官員,共同舉辦了兩場高峰會,聚焦於急性呼吸道感染疾病的疫苗防治策略,為同時接種政策的確立奠下基礎,並透過深入探討首年推動「左流右新」策略的執行情況與面臨的挑戰,包括如何提升民眾防疫識能與醫護人員的自我效能、內化接種與主動衛教意識,以及增進醫療單位執行同時接種意願與行政措施等,並建議可行目標與推動計畫。展望2025年秋冬,需持續深化政府、地方衛生單位、醫學會與醫師公會之間的協作,進一步強化「左流右新」同時接種政策,以迎接未來更嚴峻的呼吸道感染疾病防治挑戰。
(台灣家醫誌2025; 35: 1-14) DOI: 10.53106/168232812025033501001
關鍵詞:COVID-19疫苗、流感疫苗、同時接種、疫苗政策
1國立成功大學醫學院醫學系家庭醫學科、
2國立成功大學醫學院附設醫院家庭醫學部、
3國立成功大學醫學院老年學研究所、
4國立臺灣大學醫學院附設醫院小兒科、
5林口長庚紀念醫院分子感染症醫學研究中心、
6長庚大學醫學系兒童感染科、
7國立臺灣大學醫學院附設醫院內科部感染科、
8國立臺灣大學醫學院內科、
9臺北醫學大學附設醫院感染科、
10國立陽明大學醫學系內科、
11三軍總醫院感染及熱帶醫學科、
12陳宏麟診所、
13錦明耳鼻喉科診所、
14桃園巿衛生局、
15台南巿衛生局、
16衛生福利部疾病管制署、
17黃振國診所
受理日期:114年2月23日 修改日期:114年3月17日 同意刊登:114年3月25日
*通訊作者:黃振國、莊人祥 通訊地址:基隆市信義區東信路218號 Email:ckhuang218@gmail.com
Promoting Co-Administration of COVID-19 and influenza Vaccines in Taiwan: Addressing Acute Respiratory Infection Challenges
Chih-Hsing Wu1-3, Li-Min Huang4, Cheng-Hsun Chiu5,6, Yee-Chun Chen7,8, Fu-Der Wang9,10, Feng-Yee Chang11, Wang-Huei Sheng8, Hung-Lin Chen12, Ching-Ming Chou13, Wey Chia14, Tsuey-Fong Lee15, Jen-Hsiang Chuang16* and Cheng-Kuo Huang17*
Although Taiwan and the global community have entered the post-pandemic era, COVID-19 and influenza remain major respiratory threats. Despite the availability of comprehensive local healthcare services, declining public awareness has resulted in suboptimal vaccination coverage for both diseases, falling short of mitigating future surges and long-term health burdens. Globally, the co-administration of COVID-19 and influenza vaccines has been proven safe and effective. In collaboration with the Taiwan Medical Association, allied professional societies (associations) and government agencies, the Taiwan Association of Family Medicine convened two high-level summits to develop vaccination strategies for preventing acute respiratory infections. These efforts culminated in the adoption of a national co-administration policy for COVID-19 and influenza vaccination. Discussions also explored the details and challenges encountered during the first year of implementing the “Co-Administration of COVID-19 and Influenza Vaccines: Left Flu, Right COVID” (“Co-Admin”) strategy. Key topics included approaches to increase disease prevention awareness among the public and self-efficacy among healthcare professionals, to foster demand for vaccination and willingness to engage in proactive health education, and to enhance the intention and administrative measures of healthcare institutions for co-administration of both vaccines. Feasible goals and actionable plans were recommended to overcome these challenges. Looking ahead, sustained and strengthened collaboration among the government, local health authorities, andprofessional organizations—along with the “Co-Admin” vaccination policy support—will be critical for reinforcing Taiwan’s preparedness against future waves of acute respiratory infections.
(Taiwan J Fam Med 2025; 35: 1-14) DOI: 10.53106/168232812025033501001
Key words: co-administration, COVID-19 vaccines, influenza vaccines, vaccination policy
1Department of Family Medicine, College of Medicine, National Cheng Kung University; 2Department of Family Medicine,
National Cheng Kung University Hospital; 3Institute of Gerontology, College of Medicine, National Cheng Kung University
College of Medicine, National Cheng Kung University Hospital; 4Department of Pediatrics, National Taiwan University
Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan; 5Molecular Infectious Disease Research
Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 6Division of Pediatric Infectious Diseases, Department of
Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan;7Division of
Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 8Department of
Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 9Division of Infectious Diseases,
Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; 10National Yang-Ming Chiao-Tung
University, Taipei, Taiwan; 11Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-
Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 12Hung-Lin Chen Clinic; 13Jin-Ming Ear, Nose
& Throat Clinic; 14Public Health Bureau, Taoyuan City Government; 15Public Health Bureau, Tainan City Government;
16Taiwan Centers for Disease Control, Ministry of Health and Welfare; 17Cheng-Kuo Huang Clinic
Received: February 23, 2025; Revised: March 17, 2025; Accepted: March 25, 2025.
*Corresponding author
網站更新日期:114.04.25
瀏覽人數:29905329